Benign Prostatic Hyperplasia (BPH), or enlarged prostate, is a common condition affecting millions of men, especially those over 50. It can lead to uncomfortable urinary symptoms and significantly ...
Medicare Part B covers Aquablation for BPH if a person meets specific eligibility criteria, including a prostate volume of 30 to 150 cubic centimeters (cc). Medicare does not cover Aquablation in ...
NEW TECHNOLOGY: The new HYDROS™ Robotic System is the next-generation platform to treat men suffering from benign prostatic hyperplasia. (Submitted Photo) THOMASVILLE — Archbold is now offering ...
SAN JOSE, Calif., April 23, 2024 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics ® Corporation (Nasdaq: PRCT), a surgical robotics company focused on advancing patient care by developing transformative ...
CHI Memorial announces it is the first in the Chattanooga region to offer Aquablation therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH), or ...
For an estimated one in two men aged 51 to 60, benign prostatic hyperplasia (BPH), or an enlarged prostate, is the number one reason they visit the urologist. Risk factors for BPH include aging, ...
For 69-year-old Andre Price, living with an enlarged prostate was affecting every part of his life. "I was getting up every hour and a half," Price says of having to wake frequently to use the ...
GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth Medical Center (MHMC) announced today that its surgeons have performed the first Aquablation procedures to treat benign prostatic hyperplasia (BPH).
REDWOOD CITY, Calif.--(BUSINESS WIRE)--PROCEPT BioRobotics Corporation, a surgical robotics company developing intelligent solutions to transform the field of urology, has announced that the safety ...
Mar. 22—MANCHESTER — Elliot Heath System announced today that Medical Director of Elliot Acute Urological Services, Dr. Christopher Girasole, is the first provider in New Hampshire to offer ...
This is an archived article and the information in the article may be outdated. Please look at the time stamp on the story to see when it was last updated. Dr. William Van Bingham of St. Francis ...
ProVerum and Zenflow both this week announced FDA approvals for their technologies that treat benign prostatic hyperplasia ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback